Full text is available at the source.
Abstract
Selective inhibition of SNHG1, SNHG12, and SNHG30 significantly reduced both proliferation of Ewing cells and the growth of Ewing tumors.
- Over 90% of Ewing sarcomas are driven by the EWS-FLI1 fusion oncoprotein, which alters the expression of hundreds of genes.
- The role of long non-coding RNAs (lncRNAs) in Ewing sarcoma oncogenesis is largely unknown.
- Most lncRNA knockdowns had minimal effects on cell proliferation, except for SNHG1, SNHG12, and SNHG30.
- Knockdown of SNHG1, SNHG12, and SNHG30 reduced Ewing cell proliferation in vitro and tumor growth in vivo.
- A decrease in specific post-transcriptional modifications of rRNA was observed, linked to snoRNAs encoded by SNHG1 and SNHG12.
- The study suggests that the expression of certain lncRNAs may be important for maintaining cancer cell fitness in Ewing sarcoma.
Simplified